Abstract
The postoperative course of six patients with primary hyperparathyroidism and obvious radiological evidence of bone disease pretreated with 1-alpha-hydroxy vitamin D3 (1 alpha HCC) was indistinguishable from that of six patients with a similar clinical and radiological picture who were not pretreated. 1alphaHCC may increase the hypercalcaemia in some cases and cannot be recommended for the routine preparation of such patients for surgery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boyle I. T., Fogelman I., Boyce B., Thomson J. E., Beastall G. H., McIntosh W. B., McLennan I. 1alpha-hydroxyvitamin D3 in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):215s–222s. doi: 10.1111/j.1365-2265.1977.tb03384.x. [DOI] [PubMed] [Google Scholar]
- Pyrah L. N., Hodgkinson A., Anderson C. K. Primary hyperparathyroidism. Br J Surg. 1966 Apr;53(4):245–316. doi: 10.1002/bjs.1800530402. [DOI] [PubMed] [Google Scholar]